ESR1 and breast cancer: Unfortunately, the triple negative breast cancers, a subset of breast cancers clinically defined by the absence of the estrogen receptor, progesterone receptor, and HER-2 over expression, have a higher propensity to metastasize to distant visceral organs, and have a worse outcome with a high rate of recurrence after adjuvant treatment [4].